SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 198 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,502 | -66.0% | 12,510 | -25.1% | 0.00% | – |
| Q2 2023 | $22,090 | -32.7% | 16,700 | -13.1% | 0.00% | – |
| Q1 2023 | $32,805 | -45.7% | 19,223 | +1.8% | 0.00% | – |
| Q4 2022 | $60,413 | -42.5% | 18,892 | -11.5% | 0.00% | – |
| Q3 2022 | $105,000 | +18.0% | 21,350 | 0.0% | 0.00% | – |
| Q2 2022 | $89,000 | -53.6% | 21,350 | -10.7% | 0.00% | – |
| Q1 2022 | $192,000 | +20.0% | 23,897 | +12.7% | 0.00% | – |
| Q4 2021 | $160,000 | -19.6% | 21,213 | -3.5% | 0.00% | – |
| Q3 2021 | $199,000 | -18.4% | 21,976 | +8.2% | 0.00% | -100.0% |
| Q2 2021 | $244,000 | -30.9% | 20,312 | -28.0% | 0.00% | 0.0% |
| Q1 2021 | $353,000 | +37.4% | 28,192 | +69.6% | 0.00% | 0.0% |
| Q4 2020 | $257,000 | +54.8% | 16,620 | -5.1% | 0.00% | – |
| Q3 2020 | $166,000 | +3.1% | 17,505 | -1.8% | 0.00% | -100.0% |
| Q2 2020 | $161,000 | +35.3% | 17,827 | -4.3% | 0.00% | – |
| Q1 2020 | $119,000 | – | 18,634 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WASATCH ADVISORS LP | 17,986,781 | $10,788,471 | 0.07% |
| PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 254,257 | $12,790 | 0.03% |
| Long Focus Capital Management, LLC | 1,372,000 | $822,926 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 559,731 | $336 | 0.03% |
| Rokos Capital Management LLP | 6,474,348 | $3,940,936 | 0.03% |
| Golden State Equity Partners | 166,265 | $99,726 | 0.03% |
| State of Wyoming | 92,360 | $55,398 | 0.01% |
| ExodusPoint Capital Management, LP | 1,890,425 | $1,134 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 2,927,769 | $1,753 | 0.01% |
| Fort Sheridan Advisors LLC | 53,831 | $32,288 | 0.01% |